Year: 2024

Aktia Bank PlcStock exchange release 20 December 2024 at 8.30 a.m. Sakari Järvelä appointed Chief Financial Officer at Aktia Sakari Järvelä, M.Sc. (Econ), has been appointed Chief Financial Officer (CFO) at Aktia and member of Aktia’s Executive Committee. Sakari Järvelä has over 20 years of international experience, mainly in management positions in the banking and financial sector. Järvelä has a strong expertise in financial administration, reporting and strategic financial management, and he comes to Aktia from the role as CFO at the real estate investment company Citycon Plc. He also has extensive banking and financial experience from SEB and Nordea.  “I am pleased to welcome Sakari Järvelä to Aktia’s Executive Committee. Sakari has an extensive knowledge of demanding financial management processes and a strong background in the financial...

In 2025, Hepsor AS plans to disclose the consolidated financial results as follows:19 February 2025 Unaudited interim report for twelve months and Q4 202423 April 2025 Audited annual report for 202430 April 2025 Unaudited interim report for Q1 202530 July 2025 Unaudited interim report for six months and Q2 202529 October 2025 Unaudited interim report for nine months and Q3 2025Henri Laks Member of the Management Board Phone: +372 5693 9114 e-mail: henri@hepsor.ee – Hepsor AS (www.hepsor.ee) is a developer of residential and commercial real estate that operates in Estonia, Latvia, and from 2023 on the Canadian real estate market. Over the last thirteen years Hepsor has developed more than 2076 homes and 36,500 m2 of commercial space. Hepsor was the first real estate developer in the Baltic States to implement...

– SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for use in arterial replacement and repair – – In clinical testing SYMVESS was observed to have high rates of patency, or blood flow, and low rates of amputation and infection – – Highly experienced sales team already recruited and trained in preparation for commercial launch – DURHAM, N.C., Dec. 19, 2024 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the U.S. Food and Drug Administration (FDA) has granted a full approval for SYMVESS (acellular tissue engineered vessel-tyod) for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is...

VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) today announced that it has entered into amended and restated agreements (the “Amended Agreements”) with Dowa Metals & Mining Co., Ltd. (“Dowa”) regarding the Los Gatos Joint Venture (the “LGJV”). The Amended Agreements, which are effective on January 1, 2025, expand Gatos Silver’s management rights within the LGJV which will result in the Company being able to fully consolidate the financial statements of the LGJV rather than accounting for its investment in the LGJV under the equity method of accounting as is currently required. The ownership interests of the Company and Dowa in the LGJV are unchanged, at 70% and 30%, respectively. The Amended Agreements strengthen Dowa’s zinc concentrate offtake...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTCQB: GURFF | FRA: Q3J) (the “Company“) is pleased to announce that it intends to complete a non-brokered charity flow-through private placement of common shares in the capital of the Company (“Shares”) at a price of $1 per Share for aggregate gross proceeds of up to C$1,000,000 (the “Offering”). The Shares issued under the Offering are intended to qualify as “flow through shares” within the meaning of the Income Tax Act (Canada) (the “Tax Act“). The gross proceeds from the sale of the Shares will be used to incur “Canadian exploration expenses” on the Company’s projects, including at the Northwest Athabasca Project, that are...

MONTREAL, Dec. 19, 2024 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) announces that it has granted 80,000 deferred share units (“DSUs“) of the Company to Mr. Stephen Quin, an independent director, as part of his recent appointment to the Company’s board of directors announced on December 5, 2024. The DSUs were granted in accordance with the Company’s DSU plan, which is available on the Company’s website at www.osiskodev.com. ABOUT OSISKO DEVELOPMENT CORP. Osisko Development Corp. is a North American gold development company focused on past-producing mining camps located in mining friendly jurisdictions with district scale potential. The Company’s objective is to become an intermediate gold producer by advancing...

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV) (the “Company), a global leader in AI-driven retail innovation, today announced that it has entered into definitive agreements for the purchase and sale of 5,000,000 of the Company’s ordinary shares (or pre-funded warrants in lieu thereof) and warrants to purchase up to 5,000,000 ordinary shares at a purchase price of $3.00 per share (or per pre-funded warrant in lieu thereof) and accompanying warrant in a registered offering. The warrants will have an exercise price of $3.00 per share, will be exercisable immediately upon issuance and will expire on the earlier of (i) thirty days after the volume weighted average price of the ordinary shares is at or above $6.00 for five consecutive trading days and (ii) five years from the date of issuance. The closing of the...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | FRA: HW3), announces that further to its December 3, 2024 news release, the Company has closed its non-brokered private placement of flow-through units (each, a “FT Unit“) for aggregate gross proceeds in this second tranche of $4,947,433.92 (the “Offering“). The Company has issued 5,622,084 FT Units at a price of $0.88 per FT Unit, with each FT Unit comprised of one (1) common share of the Company (each, a “Common Share”) issued on a flow-through basis under the Income Tax Act (Canada) (each, a “FT Share”) and one half of one Common Share purchase warrant (each whole...